CN108771636A - 一种溶菌酶制剂 - Google Patents
一种溶菌酶制剂 Download PDFInfo
- Publication number
- CN108771636A CN108771636A CN201810918495.4A CN201810918495A CN108771636A CN 108771636 A CN108771636 A CN 108771636A CN 201810918495 A CN201810918495 A CN 201810918495A CN 108771636 A CN108771636 A CN 108771636A
- Authority
- CN
- China
- Prior art keywords
- chitosan
- lysozyme
- mixed
- skin
- purification
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000010335 lysozyme Nutrition 0.000 title claims abstract description 31
- 108010014251 Muramidase Proteins 0.000 title claims abstract description 29
- 102000016943 Muramidase Human genes 0.000 title claims abstract description 29
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 title claims abstract description 29
- 229960000274 lysozyme Drugs 0.000 title claims abstract description 27
- 239000004325 lysozyme Substances 0.000 title claims abstract description 27
- 239000000203 mixture Substances 0.000 title claims abstract description 17
- 238000009472 formulation Methods 0.000 title claims abstract description 16
- 102000004317 Lyases Human genes 0.000 claims abstract description 27
- 108090000856 Lyases Proteins 0.000 claims abstract description 27
- 241000894006 Bacteria Species 0.000 claims abstract description 20
- 239000007788 liquid Substances 0.000 claims abstract description 20
- 229920001661 Chitosan Polymers 0.000 claims abstract description 16
- 229920002545 silicone oil Polymers 0.000 claims abstract description 15
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 12
- 239000011148 porous material Substances 0.000 claims abstract description 12
- 239000004480 active ingredient Substances 0.000 claims abstract description 3
- 238000013019 agitation Methods 0.000 claims abstract description 3
- 238000000746 purification Methods 0.000 claims description 31
- 239000012752 auxiliary agent Substances 0.000 claims description 27
- 239000000284 extract Substances 0.000 claims description 16
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 15
- 238000002360 preparation method Methods 0.000 claims description 14
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 12
- 239000000243 solution Substances 0.000 claims description 11
- 101710157833 Lysozyme A Proteins 0.000 claims description 9
- 238000003756 stirring Methods 0.000 claims description 9
- 239000000341 volatile oil Substances 0.000 claims description 7
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- 239000003921 oil Substances 0.000 claims description 6
- 235000019198 oils Nutrition 0.000 claims description 6
- 239000003960 organic solvent Substances 0.000 claims description 6
- 239000013049 sediment Substances 0.000 claims description 6
- 239000000377 silicon dioxide Substances 0.000 claims description 6
- 239000006228 supernatant Substances 0.000 claims description 6
- 238000005406 washing Methods 0.000 claims description 6
- 239000000126 substance Substances 0.000 claims description 5
- 102000004190 Enzymes Human genes 0.000 claims description 4
- 108090000790 Enzymes Proteins 0.000 claims description 4
- 230000002378 acidificating effect Effects 0.000 claims description 4
- 229940088598 enzyme Drugs 0.000 claims description 4
- 239000000686 essence Substances 0.000 claims description 4
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims description 3
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims description 3
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims description 3
- 241000196324 Embryophyta Species 0.000 claims description 3
- 241000218378 Magnolia Species 0.000 claims description 3
- 241000727169 Prinsepia utilis Species 0.000 claims description 3
- 241000241413 Propolis Species 0.000 claims description 3
- 244000046146 Pueraria lobata Species 0.000 claims description 3
- 235000010575 Pueraria lobata Nutrition 0.000 claims description 3
- 229960000458 allantoin Drugs 0.000 claims description 3
- 230000015572 biosynthetic process Effects 0.000 claims description 3
- 210000002969 egg yolk Anatomy 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 238000004108 freeze drying Methods 0.000 claims description 3
- 239000012535 impurity Substances 0.000 claims description 3
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 claims description 3
- 235000008696 isoflavones Nutrition 0.000 claims description 3
- 230000002045 lasting effect Effects 0.000 claims description 3
- 210000004324 lymphatic system Anatomy 0.000 claims description 3
- 239000012528 membrane Substances 0.000 claims description 3
- 229940041616 menthol Drugs 0.000 claims description 3
- 239000011259 mixed solution Substances 0.000 claims description 3
- 229920000642 polymer Polymers 0.000 claims description 3
- 239000002244 precipitate Substances 0.000 claims description 3
- 229940069949 propolis Drugs 0.000 claims description 3
- 239000010666 rose oil Substances 0.000 claims description 3
- 235000019719 rose oil Nutrition 0.000 claims description 3
- 150000004756 silanes Chemical class 0.000 claims description 3
- 235000012239 silicon dioxide Nutrition 0.000 claims description 3
- 244000068988 Glycine max Species 0.000 claims description 2
- 235000010469 Glycine max Nutrition 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims description 2
- 239000007864 aqueous solution Substances 0.000 claims description 2
- 239000002131 composite material Substances 0.000 claims description 2
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 claims description 2
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 claims 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims 1
- 238000004945 emulsification Methods 0.000 claims 1
- 239000011574 phosphorus Substances 0.000 claims 1
- 229910052698 phosphorus Inorganic materials 0.000 claims 1
- 239000011734 sodium Substances 0.000 claims 1
- 229910052708 sodium Inorganic materials 0.000 claims 1
- 238000010792 warming Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 13
- 229920001296 polysiloxane Polymers 0.000 abstract description 5
- 150000003384 small molecules Chemical class 0.000 abstract description 2
- 239000002537 cosmetic Substances 0.000 description 5
- 235000013601 eggs Nutrition 0.000 description 5
- 238000000034 method Methods 0.000 description 4
- 210000000481 breast Anatomy 0.000 description 3
- 210000002421 cell wall Anatomy 0.000 description 3
- 210000002751 lymph Anatomy 0.000 description 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
- MOMKYJPSVWEWPM-UHFFFAOYSA-N 4-(chloromethyl)-2-(4-methylphenyl)-1,3-thiazole Chemical group C1=CC(C)=CC=C1C1=NC(CCl)=CS1 MOMKYJPSVWEWPM-UHFFFAOYSA-N 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 2
- ZNZYKNKBJPZETN-WELNAUFTSA-N Dialdehyde 11678 Chemical compound N1C2=CC=CC=C2C2=C1[C@H](C[C@H](/C(=C/O)C(=O)OC)[C@@H](C=C)C=O)NCC2 ZNZYKNKBJPZETN-WELNAUFTSA-N 0.000 description 2
- 101001018100 Homo sapiens Lysozyme C Proteins 0.000 description 2
- 229920002385 Sodium hyaluronate Polymers 0.000 description 2
- 229930003451 Vitamin B1 Natural products 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 229920002674 hyaluronan Polymers 0.000 description 2
- 229960003160 hyaluronic acid Drugs 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- 229940051921 muramidase Drugs 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 229940010747 sodium hyaluronate Drugs 0.000 description 2
- 235000019983 sodium metaphosphate Nutrition 0.000 description 2
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 229960003495 thiamine Drugs 0.000 description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 2
- 239000011691 vitamin B1 Substances 0.000 description 2
- 235000010374 vitamin B1 Nutrition 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- DQJCDTNMLBYVAY-ZXXIYAEKSA-N (2S,5R,10R,13R)-16-{[(2R,3S,4R,5R)-3-{[(2S,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5-(ethylamino)-6-hydroxy-2-(hydroxymethyl)oxan-4-yl]oxy}-5-(4-aminobutyl)-10-carbamoyl-2,13-dimethyl-4,7,12,15-tetraoxo-3,6,11,14-tetraazaheptadecan-1-oic acid Chemical compound NCCCC[C@H](C(=O)N[C@@H](C)C(O)=O)NC(=O)CC[C@H](C(N)=O)NC(=O)[C@@H](C)NC(=O)C(C)O[C@@H]1[C@@H](NCC)C(O)O[C@H](CO)[C@H]1O[C@H]1[C@H](NC(C)=O)[C@@H](O)[C@H](O)[C@@H](CO)O1 DQJCDTNMLBYVAY-ZXXIYAEKSA-N 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- 102000006410 Apoproteins Human genes 0.000 description 1
- 108010083590 Apoproteins Proteins 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 102000002068 Glycopeptides Human genes 0.000 description 1
- 108010015899 Glycopeptides Proteins 0.000 description 1
- JZKXXXDKRQWDET-QMMMGPOBSA-N L-m-tyrosine Chemical group OC(=O)[C@@H](N)CC1=CC=CC(O)=C1 JZKXXXDKRQWDET-QMMMGPOBSA-N 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 241000700647 Variola virus Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 230000003255 anti-acne Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 150000002515 isoflavone derivatives Chemical class 0.000 description 1
- 230000001926 lymphatic effect Effects 0.000 description 1
- 210000003810 lymphokine-activated killer cell Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000005808 skin problem Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/66—Enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/31—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/736—Chitin; Chitosan; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/987—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
- A61K8/988—Honey; Royal jelly, Propolis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Zoology (AREA)
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cosmetics (AREA)
Abstract
本发明涉及到一种溶菌酶制剂，包括溶酶菌A试剂，所述溶酶菌A试剂中有效成分为溶菌酶提纯液与硅油在高速搅拌下形成的溶酶菌‑壳聚糖‑硅油。将其混入其他护肤品组分中涂抹在皮肤上时，硅油大分子因自身分子量大以及空间位阻的情况无法从毛孔深入皮肤深处进行清洁，因此在皮肤表面形成均匀的水膜，壳聚糖作为载体，对连接在其分子链表面的溶酶菌有良好的缓释作用；一部分壳聚糖与硅油大分子一同覆盖在皮肤表面，另一部分位于毛孔处即毛孔中的溶菌酶和皮肤表面的硅油分子之间，溶酶菌小分子从毛孔处深入进皮肤中，起到深层净化皮肤和人体内环境的作用，之后壳聚糖释放完所有的溶菌酶后对毛孔缩小有一定的作用效果。
Description
技术领域
本发明涉及一种溶菌酶，特别涉及一种溶菌酶制剂。
背景技术
目前化妆品种类繁多，其作用、效果也大有不同，例如祛斑、祛痘、美白、修复等；但是这些美容产品大多是治标不治本，无法真正的从根源去除皮肤表面的色斑、闭口、痘痘等，而究其根源，则是因为人体内部经络不通、血液淤堵，从而导致肤色暗沉、体虚肥胖、免疫功能下降等情况。
溶菌酶(lysozyme)又称胞壁质酶(muramidase)或N-乙酰胞壁质聚糖水解酶(N-acetylmuramide glycanohydrlase)，是一种能水解致病菌中黏多糖的碱性酶。主要通过破坏细胞壁中的N-乙酰胞壁酸和N-乙酰氨基葡糖之间的β-1,4糖苷键，使细胞壁不溶性黏多糖分解成可溶性糖肽，导致细胞壁破裂内容物逸出而使细菌溶解。溶菌酶还可与带负电荷的病毒蛋白直接结合，与DNA、RNA、脱辅基蛋白形成复盐，使病毒失活。因此，该酶具有抗菌、消炎、抗病毒等作用。
目前，将溶菌酶添加在化妆品中能对部分皮肤问题有效改善，例如各类斑的去除，如申请号为“201510414877.X”的中国专利所公开的一种人溶菌酶精华液，对皮肤具有明显的美白滋润、护肤美容的效果。
例如国际公布号为“WO2006/079288A1”的PCT国际专利所公开的一种人溶菌酶在制备治疗痤疮的化妆品中的应用，可有效用于痤疮的治疗。
综上所述，溶菌酶在化妆品领域的添加应用已然成问一种全新的领域，也为化妆品制造提供了一种全新的思路。
本发明公开一共溶菌酶制剂，对人体具有良好的净化效果，使涂覆在皮肤上的化妆品发挥出更大的功效。
发明内容
本发明的目的是提供一种溶菌酶制剂。
本发明的上述技术目的是通过以下技术方案得以实现的：一种溶菌酶制剂，包括溶酶菌A试剂，所述溶酶菌A试剂中有效成分为溶菌酶提纯液与硅油在高速搅拌下形成的溶酶菌-壳聚糖-硅油。
作为优选，还包括以下组分，以下组分按照重量计：
作为优选，所述溶酶菌-壳聚糖-硅油的制备方法主要包括以下步骤：
步骤1，蛋液分离：去除蛋黄，去除杂质；
步骤2，预备液制备，将二氧化硅作为制孔剂，混入高分子壳聚糖中，制备得到壳聚糖多孔膜：将壳聚糖溶解在低浓度的乙酸溶液中形成壳聚糖-乙酸溶液，将壳聚糖-乙酸溶液逐滴添加至液体石蜡中，滴加过程中持续搅拌，滴加完毕后高速搅拌至乳化；将低浓度戊二醛溶液与碱性二氧化硅混合并逐滴滴加至混合溶液中，搅拌至完全混合后，离心过滤5-8min，去除上层清液，将下层淡黄色沉淀收集，多次洗涤得到纯净物后，冻干研磨成粉；
步骤3：将预备液体与步骤1中制备的蛋液在微酸性环境下混合，静置24-48h后，离心8-15分钟后去除上层清液取下层沉淀；
步骤4：将卤代硅烷与有机溶剂混合后逐滴滴加至步骤3中下层沉淀中，搅拌并升温至50-58℃，搅拌10-20h后，减压蒸馏/减压干燥得到高浓度溶酶菌-壳聚糖-硅油复合物质；
步骤5：多次洗涤后收集。
作为优选，所述步骤3中微酸环境为偏磷酸钠水溶液，所述步骤4中有机溶剂为DMA。
作为优选，还包括辅助制剂A，所述辅助制剂A包括青刺果油提取物、玫瑰花油提取物、白兰花油提取物；所述溶菌酶A试剂与辅助制剂A混合形成净化精油。
作为优选，还包括辅助制剂B，所述辅助制剂B包括葛根提取物、大豆异黄酮提取物、植物胎盘液；所述辅助制剂B与溶菌酶A制剂混合形成净化精华。
作为优选，还包括辅助制剂C，所述辅助制剂C包括蜂胶提取物、薄荷脑、尿囊素；所述辅助制剂C和溶菌酶A制剂混合形成净化霜。
作为优选，将所述净化精油、净化净化或净化霜均匀涂抹在身体淋巴系统所在位置后配合按摩手法按摩直至吸收。
综上所述，本发明具有以下有益效果：
1.本方案中的有效成为溶酶菌-壳聚糖-硅油，将其混入其他护肤品组分中涂抹在皮肤上时，硅油大分子因自身分子量大以及空间位阻的情况无法从毛孔深入皮肤深处进行清洁，因此在皮肤表面形成均匀的水膜，壳聚糖作为载体，对连接在其分子链表面的溶酶菌有良好的缓释作用；一部分壳聚糖与硅油大分子一同覆盖在皮肤表面，另一部分位于毛孔处即毛孔中的溶菌酶和皮肤表面的硅油分子之间，溶酶菌小分子从毛孔处深入进皮肤中，起到深层净化皮肤和人体内环境的的作用，之后壳聚糖释放完所有的溶菌酶后对毛孔缩小有一定的作用效果；
2.目前，溶酶菌的来源主要是鸡蛋清溶液中的溶菌酶多肽链，主要由129个氨基酸残基组成，包括6个色氨基残基、3个络氨酸残基和4对二硫键，以上三种基团的存在决定了溶酶菌的活性；而现有技术中对溶酶菌的制备提纯主要方法为直接结晶法、粒子交换法和亲和层析法，以上几种制备方法工艺复杂、成本较高，且对其上几种影响溶酶菌活性的残基的保留率有所影响；而本方案中通过温和的吸附手段取得鸡蛋清中的溶酶菌，极大程度上保留了溶酶菌的活性，且制备、提纯成本相对较低，操作简单易实施；
3.将硅油-溶酶菌-壳聚糖与角鲨烷、透明质酸、氨基酸、维生素B1、玻尿酸等混合，去离子水帮助溶解和在溶剂中的均匀分布，表面活性剂促使不溶物质溶解；以上几种均对皮肤有良好的保湿、补水、修复等功效，微生物B1帮助皮肤毛孔打开溶酶菌进入，角鲨烷等可帮助溶酶菌作用完毕后重新修复皮肤，使皮肤容光焕发；
4.将本方案中的溶菌酶A试剂分别添加至辅助制剂A、辅助制剂B、辅助制剂C中形成净化精油、净化净化、净化霜；将其涂抹在皮肤表面并配合按摩手法，有助于皮肤对以上物质的吸收，可加速经络循环代写、放松肌肉、安抚背部疲劳、疏通乳房对应反射经络，预防因置放堆积形成的背部变形；净化净化涂抹在胸部可激活乳房内腺体、腺泡，补充乳房内需要的大量营养和水分，达到丰盈饱满的效果；净化霜具有疏通淋巴、改善淋巴淤堵，给淋巴系统输送动能，增强NK，LAK细胞的或于都，有效促进淋巴循环代谢预防疾病。
具体实施方式
本具体实施例仅仅是对本发明的解释，其并不是对本发明的限制，本领域技术人员在阅读完本说明书后可以根据需要对本实施例做出没有创造性贡献的修改，但只要在本发明的权利要求范围内都受到专利法的保护。
实施例：
一种溶菌酶制剂，主要包括溶酶菌-硅油-壳聚糖，制备提纯方法如下所示：
步骤1，蛋液分离：去除蛋黄，去除杂质；
步骤2，预备液制备，将二氧化硅作为制孔剂，混入高分子壳聚糖中，制备得到壳聚糖多孔膜：将壳聚糖溶解在低浓度的乙酸溶液中形成壳聚糖-乙酸溶液，将壳聚糖-乙酸溶液逐滴添加至液体石蜡中，滴加过程中持续搅拌，滴加完毕后高速搅拌至乳化；将低浓度戊二醛溶液与碱性二氧化硅混合并逐滴滴加至混合溶液中，搅拌至完全混合后，离心过滤5-8min，去除上层清液，将下层淡黄色沉淀收集，多次洗涤得到纯净物后，冻干研磨成粉；
步骤3：将预备液体与步骤1中制备的蛋液在微酸性环境下混合，静置24-48h后，离心8-15分钟后去除上层清液取下层沉淀；利用偏磷酸钠营造微酸性环境；
步骤4：将卤代硅烷与有机溶剂混合后逐滴滴加至步骤3中下层沉淀中，搅拌并升温至50-58℃，搅拌10-20h后，减压蒸馏/减压干燥得到高浓度硅油-溶酶菌-壳聚糖复合物质，有机溶剂采用DMA；
步骤5：多次洗涤后收集。
溶菌酶A试剂中还包括角鲨烷、透明质酸、氨基酸、维生素B1、表面活性剂、玻尿酸、去离子水，实施例1-实施例5中各物质组成相同但具体含量不同，详见下表1所示；
表1：
将实施例1-实施例5中制备得到溶酶菌A试剂分别添加至辅助制剂A、辅助制剂B和辅助制剂C中形成净化精油、净化精华和净化霜。
辅助制剂A包括：青刺果油提取物、玫瑰花油提取物、白兰花油提取物。
辅助制剂B包括：葛根提取物、大豆异黄酮提取物、植物胎盘液。
辅助制剂C包括：蜂胶提取物、薄荷脑、尿囊素。
辅助制剂A、辅助制剂B和辅助制剂C中各物质的比例关系为1:1:1，溶菌酶A试剂的添加量为25％-50％。
将制备得到的净化精油、净化净化或净化霜均匀涂抹在身体淋巴系统所在位置后配合按摩手法按摩直至吸收，持续涂抹1-3疗程后，皮肤状态有效改善。
Claims (8)
1.一种溶菌酶制剂，其特征在于，包括溶酶菌A试剂，所述溶酶菌A试剂中有效成分为溶菌酶提纯液与硅油在高速搅拌下形成的溶酶菌-壳聚糖-硅油。
2.根据权利要求1所述的一种溶菌酶制剂，其特征在于，还包括以下组分，以下组分按照重量计：
3.根据权利要求2所述的一种溶菌酶制剂，其特征在于，所述溶酶菌-壳聚糖-硅油的制备方法主要包括以下步骤：
步骤1，蛋液分离：去除蛋黄，去除杂质；
步骤2，预备液制备，将二氧化硅作为制孔剂，混入高分子壳聚糖中，制备得到壳聚糖多孔膜：将壳聚糖溶解在低浓度的乙酸溶液中形成壳聚糖-乙酸溶液，将壳聚糖-乙酸溶液逐滴添加至液体石蜡中，滴加过程中持续搅拌，滴加完毕后高速搅拌至乳化；将低浓度戊二醛溶液与碱性二氧化硅混合并逐滴滴加至混合溶液中，搅拌至完全混合后，离心过滤5-8min，去除上层清液，将下层淡黄色沉淀收集，多次洗涤得到纯净物后，冻干研磨成粉；
步骤3：将预备液体与步骤1中制备的蛋液在微酸性环境下混合，静置24-48h后，离心8-15分钟后去除上层清液取下层沉淀；
步骤4：将卤代硅烷与有机溶剂混合后逐滴滴加至步骤3中下层沉淀中，搅拌并升温至50-58℃，搅拌10-20h后，减压蒸馏/减压干燥得到高浓度溶酶菌-壳聚糖-硅油复合物质；
步骤5：多次洗涤后收集。
4.根据权利要求3所述的一种溶菌酶制剂，其特征在于：所述步骤3中微酸环境为偏磷酸钠水溶液，所述步骤4中有机溶剂为DMA。
5.根据权利要求4所述的一种溶菌酶制剂，其特征在于：还包括辅助制剂A，所述辅助制剂A包括青刺果油提取物、玫瑰花油提取物、白兰花油提取物；所述溶菌酶A试剂与辅助制剂A混合形成净化精油。
6.根据权利要求5所述的一种溶菌酶制剂，其特征在于：还包括辅助制剂B，所述辅助制剂B包括葛根提取物、大豆异黄酮提取物、植物胎盘液；所述辅助制剂B与溶菌酶A制剂混合形成净化精华。
7.根据权利要求6所述的一种溶菌酶制剂，其特征在于：还包括辅助制剂C，所述辅助制剂C包括蜂胶提取物、薄荷脑、尿囊素；所述辅助制剂C和溶菌酶A制剂混合形成净化霜。
8.根据权利要求7所述的一种溶菌酶制剂，其特征在于：将所述净化精油、净化净化或净化霜均匀涂抹在身体淋巴系统所在位置后配合按摩手法按摩直至吸收。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810918495.4A CN108771636B (zh) | 2018-08-13 | 2018-08-13 | 一种溶菌酶制剂 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810918495.4A CN108771636B (zh) | 2018-08-13 | 2018-08-13 | 一种溶菌酶制剂 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN108771636A true CN108771636A (zh) | 2018-11-09 |
| CN108771636B CN108771636B (zh) | 2021-03-26 |
Family
ID=64028638
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810918495.4A Expired - Fee Related CN108771636B (zh) | 2018-08-13 | 2018-08-13 | 一种溶菌酶制剂 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108771636B (zh) |
Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103160482A (zh) * | 2013-03-14 | 2013-06-19 | 江苏大学 | 一种共分离制备鸡蛋清溶菌酶与活性蛋白的方法 |
| CN104224618A (zh) * | 2014-08-27 | 2014-12-24 | 王晓伟 | 一种甲壳素天然抗菌营养染发剂 |
| CN104399067A (zh) * | 2014-11-07 | 2015-03-11 | 南京昊羽农业科技有限公司 | 一种装载溶菌酶的壳聚糖微球兽药制剂及其制备方法 |
| CN104398401A (zh) * | 2014-12-10 | 2015-03-11 | 唯美度科技（北京）有限公司 | 一种令肌肤清新无味的喷剂 |
| CN104688789A (zh) * | 2015-02-12 | 2015-06-10 | 领思科技(大连)有限公司 | 番木瓜籽提取物缓释制剂及其应用 |
| CN104800099A (zh) * | 2015-05-07 | 2015-07-29 | 宋子奎 | 一种皮肤清洗剂及其制备方法 |
| CN106726716A (zh) * | 2016-11-12 | 2017-05-31 | 然久生物科技(上海)有限公司 | 洗发水及其制备方法 |
| CN107475221A (zh) * | 2017-09-19 | 2017-12-15 | 青岛农业大学 | 一种新型溶菌酶制剂及其制备方法 |
| WO2018136909A1 (en) * | 2017-01-23 | 2018-07-26 | Savior Lifetec Corporation | Preparation of microparticles of an active ingredient |
-
2018
- 2018-08-13 CN CN201810918495.4A patent/CN108771636B/zh not_active Expired - Fee Related
Patent Citations (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103160482A (zh) * | 2013-03-14 | 2013-06-19 | 江苏大学 | 一种共分离制备鸡蛋清溶菌酶与活性蛋白的方法 |
| CN104224618A (zh) * | 2014-08-27 | 2014-12-24 | 王晓伟 | 一种甲壳素天然抗菌营养染发剂 |
| CN104399067A (zh) * | 2014-11-07 | 2015-03-11 | 南京昊羽农业科技有限公司 | 一种装载溶菌酶的壳聚糖微球兽药制剂及其制备方法 |
| CN104398401A (zh) * | 2014-12-10 | 2015-03-11 | 唯美度科技（北京）有限公司 | 一种令肌肤清新无味的喷剂 |
| CN104688789A (zh) * | 2015-02-12 | 2015-06-10 | 领思科技(大连)有限公司 | 番木瓜籽提取物缓释制剂及其应用 |
| CN104800099A (zh) * | 2015-05-07 | 2015-07-29 | 宋子奎 | 一种皮肤清洗剂及其制备方法 |
| CN106726716A (zh) * | 2016-11-12 | 2017-05-31 | 然久生物科技(上海)有限公司 | 洗发水及其制备方法 |
| WO2018136909A1 (en) * | 2017-01-23 | 2018-07-26 | Savior Lifetec Corporation | Preparation of microparticles of an active ingredient |
| CN107475221A (zh) * | 2017-09-19 | 2017-12-15 | 青岛农业大学 | 一种新型溶菌酶制剂及其制备方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN108771636B (zh) | 2021-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106832439A (zh) | 一种用于全血成分保护的新型气凝胶多功能即用型复合材料及其制备方法 | |
| KR100613554B1 (ko) | 화장재료 | |
| CN106928908A (zh) | 一种新型的气凝胶多功能材料及其制备方法 | |
| CN104717960A (zh) | 透明质酸凝胶及其制备方法 | |
| CN101180034B (zh) | 毛发护理制剂 | |
| JP2005501805A5 (zh) | ||
| CN101451157A (zh) | 一种低分子量海参多糖的制备方法 | |
| CN101469338A (zh) | 北虫草多肽的酶解制备方法与产品 | |
| CN107582456A (zh) | 一种柚子美肌沐浴露及其生产方法 | |
| JPS63310807A (ja) | 発泡性化粧料 | |
| WO2007131424A1 (fr) | Procédé de préparation de compositions de protéoglycane et de collagène à faible poids moléculaire, produits résultants et utilisations de ceux-ci | |
| CN102178630A (zh) | 生物酸的化妆品应用方法及生物酸化妆品制剂 | |
| CN103637978A (zh) | 一种稳定的含菠萝蛋白酶的凝胶 | |
| CN109453083A (zh) | 一种保湿舒敏组合物及其应用 | |
| CN108771636A (zh) | 一种溶菌酶制剂 | |
| US7429561B2 (en) | Method for stimulating cell growth using sponge protein hydrolysates | |
| JPS61257906A (ja) | パツク化粧料 | |
| CN108186438A (zh) | 一种含有细胞生长因子的晒后修复凝胶及其制备方法 | |
| CN107582430A (zh) | 一种青稞β‑葡聚糖‑聚天冬氨酸复合物的制备和应用方法 | |
| CN1572292A (zh) | 化装料 | |
| CN105362089B (zh) | 一种美白滋润霜及其制备方法 | |
| CN101365464A (zh) | 一种环氧化合物的应用 | |
| JP2008208059A (ja) | 糖ウンデシレン酸エステルを含有する皮膚外用剤 | |
| CN103845267B (zh) | 一种滋润美容霜及其制备方法 | |
| CN108992387A (zh) | 中药三白祛痘补水面膜及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20210326 |